Woodley Farra Manion Portfolio Management Inc Gilead Sciences, Inc. Transaction History

Woodley Farra Manion Portfolio Management Inc

$1.96 Billion
Q3 2024

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 05, 2020	SELL	$62.1 - $78.08 $25,647 - $32,247	-413 Closed	0 $0
Q1 2020 May 08, 2020	SELL	$62.63 - $80.22 $33,507 - $42,917	-535 Reduced 56.43%	413 $31,000
Q4 2019 Feb 14, 2020	BUY	$61.62 - $67.78 $58,415 - $64,255	948 New	948 $62,000
Q3 2019 Nov 13, 2019	SELL	$62.51 - $69.0 $232,537 - $256,680	-3,720 Closed	0 $0
Q2 2019 Aug 12, 2019	SELL	$61.87 - $69.38 $161,480 - $181,081	-2,610 Reduced 41.23%	3,720 $251,000
Q1 2019 May 14, 2019	SELL	$62.53 - $70.05 $20.8 Million - $23.3 Million	-333,258 Reduced 98.14%	6,330 $412,000
Q4 2018 Feb 12, 2019	SELL	$60.54 - $79.0 $1.57 Million - $2.05 Million	-25,952 Reduced 7.1%	339,588 $21.2 Million
Q3 2018 Nov 13, 2018	BUY	$71.28 - $78.92 $96,228 - $106,542	1,350 Added 0.37%	365,540 $28.2 Million
Q2 2018 Aug 13, 2018	BUY	$64.88 - $75.68 $374,811 - $437,203	5,777 Added 1.61%	364,190 $25.8 Million
Q1 2018 May 14, 2018	BUY	$72.84 - $88.8 $11.4 Million - $13.9 Million	156,855 Added 77.82%	358,413 $27 Million
Q4 2017 Feb 14, 2018	SELL	$71.15 - $83.52 $1.49 Million - $1.75 Million	-20,926 Reduced 9.41%	201,558 $14.4 Million
Q3 2017 Nov 13, 2017	BUY	$72.11 - $85.47 $16 Million - $19 Million	222,484	222,484 $18 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.1 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.07 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.71 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.56 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodley Farra Manion Portfolio Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Woodley Farra Manion Portfolio Management Inc with notifications on news.

Account